activity
20192021
most citedTechnical Report: Quality Assessment Tool for Machine Learning with Clinical CT

4 citations · 6 across the 5 of their papers we have counts for

collaborators

7 papers

cs.CV20214 cited

Technical Report: Quality Assessment Tool for Machine Learning with Clinical CT

Riqiang Gao, Mirza S. Khan, Yucheng Tang +6

Image Quality Assessment (IQA) is important for scientific inquiry, especially in medical imaging and machine learning. Potential data quality issues can be exacerbated when human-…

eess.IV2021

Lung Cancer Risk Estimation with Incomplete Data: A Joint Missing Imputation Perspective

Riqiang Gao, Yucheng Tang, Kaiwen Xu +7

Data from multi-modality provide complementary information in clinical prediction, but missing data in clinical cohorts limits the number of subjects in multi-modal learning contex…

eess.IV2020

Development and Characterization of a Chest CT Atlas

Kaiwen Xu, Riqiang Gao, Mirza S. Khan +8

A major goal of lung cancer screening is to identify individuals with particular phenotypes that are associated with high risk of cancer. Identifying relevant phenotypes is complic…

eess.IV2020

Deep Multi-path Network Integrating Incomplete Biomarker and Chest CT Data for Evaluating Lung Cancer Risk

Riqiang Gao, Yucheng Tang, Kaiwen Xu +7

Clinical data elements (CDEs) (e.g., age, smoking history), blood markers and chest computed tomography (CT) structural features have been regarded as effective means for assessing…

cs.CV20192 cited

Internal-transfer Weighting of Multi-task Learning for Lung Cancer Detection

Yiyuan Yang, Riqiang Gao, Yucheng Tang +6

Recently, multi-task networks have shown to both offer additional estimation capabilities, and, perhaps more importantly, increased performance over single-task networks on a "main…

cs.CV2019

Deep Multi-task Prediction of Lung Cancer and Cancer-free Progression from Censored Heterogenous Clinical Imaging

Riqiang Gao, Lingfeng Li, Yucheng Tang +6

Annual low dose computed tomography (CT) lung screening is currently advised for individuals at high risk of lung cancer (e.g., heavy smokers between 55 and 80 years old). The reco…